Decoding muscle alternative splicing

Current Opinion in Genetics and Development

Volumn 21, Issue 4, 2011, Pages 380-387

  Llorian, Miriam ^a   Smith, Christopher WJ ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BRANCH POINT BINDING PROTEIN; COMPLEMENTARY DNA; CONTRACTILE PROTEIN; MUSCLE PROTEIN; MUSCLEBLIND LIKE PROTEIN; POLYPYRIMIDINE TRACT BINDING PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; BINDING SITE; GENE DISRUPTION; GENE LOCATION; GENE SYNTHESIS; GENE TARGETING; GENETIC CODE; MATHEMATICAL COMPUTING; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MORPHOLOGICAL TRAIT; MUSCLE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MYOTONIC DYSTROPHY; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; RNA PROCESSING; RNA TRANSLATION; SEQUENCE ANALYSIS; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

ALTERNATIVE SPLICING; ANIMALS; CELL DIFFERENTIATION; HUMANS; MUSCLES; RNA SPLICE SITES; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 79960930307     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2011.03.006     Document Type: Review

References (71)

1. Andreadis A., Gallego M.E., Nadal-Ginard B. Generation of protein isoform diversity by alternative splicing: mechanistic and biological implications. Annu Rev Cell Biol 1987, 3:207-242.
2. Breitbart R.E., Nguyen H.T., Medford R.M., Destree A.T., Mahdavi V., Nadal-Ginard B. Intricate combinatorial patterns of exon splicing generate multiple regulated troponin T isoforms from a single gene. Cell 1985, 41:67-82.
3. Nilsen T.W., Graveley B.R. Expansion of the eukaryotic proteome by alternative splicing. Nature 2010, 463:457-463.
4. Gooding C., Smith C.W.J. Tropomyosin exons as models for alternative splicing. Adv Exp Med Biol 2008, 644:27-42.
5. Ladd A.N., Charlet N., Cooper T.A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol 2001, 21:1285-1296.
6. Goo Y.H., Cooper T.A. CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA. Nucleic Acids Res 2009, 37:4275-4286.
7. Spellman R., Smith C.W.J. Novel modes of splicing repression by PTB. Trends Biochem Sci 2006, 31:73-76.
8. Chen C.D., Kobayashi R., Helfman D.M. Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene. Genes Dev 1999, 13:593-606.
9. Pascual M., Vicente M., Monferrer L., Artero R. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation 2006, 74:65-80.
10. Kuroyanagi H. Fox-1 family of RNA-binding proteins. Cell Mol Life Sci 2009, 66:3895-3907.
11. Sureau A., Sauliere J., Expert-Bezancon A., Marie J. CELF and PTB proteins modulate the inclusion of the beta-tropomyosin exon 6B during myogenic differentiation. Exp Cell Res 2011, 317:94-106.
12. Charlet B.N., Logan P., Singh G., Cooper T.A. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol Cell 2002, 9:649-658.
13. Gromak N., Matlin A.J., Cooper T.A., Smith C.W.J. Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. RNA 2003, 9:443-456.
14. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J 2004, 23:3103-3112.
15. Kino Y., Washizu C., Oma Y., Onishi H., Nezu Y., Sasagawa N., Nukina N., Ishiura S. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res 2009, 37:6477-6490.
16. Castle J.C., Zhang C., Shah J.K., Kulkarni A.V., Kalsotra A., Cooper T.A., Johnson J.M. Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat Genet 2008, 40:1416-1425.
17. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., van Baren M.J., Salzberg S.L., Wold B.J., Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010, 28:511-515.
18. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
19. Fox-Walsh K.L., Hertel K.J. Splice-site pairing is an intrinsically high fidelity process. Proc Natl Acad Sci U S A 2009, 106:1766-1771.
20. Pickrell J.K., Pai A.A., Gilad Y., Pritchard J.K. Noisy splicing drives mRNA isoform diversity in human cells. PLoS Genet 2010, 6:e1001236.
21. Pan Q., Shai O., Misquitta C., Zhang W., Saltzman A.L., Mohammad N., Babak T., Siu H., Hughes T.R., Morris Q.D., et al. Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. Mol Cell 2004, 16:929-941.
22. Das D., Clark T.A., Schweitzer A., Yamamoto M., Marr H., Arribere J., Minovitsky S., Poliakov A., Dubchak I., Blume J.E., et al. A correlation with exon expression approach to identify cis-regulatory elements for tissue-specific alternative splicing. Nucleic Acids Res 2007, 35:4845-4857.
23. Sugnet C.W., Srinivasan K., Clark T.A., O'Brien G., Cline M.S., Wang H., Williams A., Kulp D., Blume J.E., Haussler D., et al. Unusual intron conservation near tissue-regulated exons found by splicing microarrays. PLoS Comput Biol 2006, 2:e4.
24. Calarco J.A., Saltzman A.L., Ip J.Y., Blencowe B.J. Technologies for the global discovery and analysis of alternative splicing. Adv Exp Med Biol 2007, 623:64-84.
25. Corioni M., Antih N., Tanackovic G., Zavolan M., Kramer A. Analysis of in situ pre-mRNA targets of human splicing factor SF1 reveals a function in alternative splicing. Nucleic Acids Res 2011, 39:1868-1879.
26. Galarneau A., Richard S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol 2005, 12:691-698.
27. Barash Y., Calarco J.A., Gao W., Pan Q., Wang X., Shai O., Blencowe B.J., Frey B.J. Deciphering the splicing code. Nature 2010, 465:53-59.
28. Corvelo A., Hallegger M., Smith C.W., Eyras E. Genome-wide association between branch point properties and alternative splicing. PLoS Comput Biol 2010, 6:e1001016.
29. Boutz P.L., Stoilov P., Li Q., Lin C.H., Chawla G., Ostrow K., Shiue L., Ares M., Black D.L. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 2007, 21:1636-1652.
30. Makeyev E.V., Zhang J., Carrasco M.A., Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 2007, 27:435-448.
31. Damianov A., Black D.L. Autoregulation of Fox protein expression to produce dominant negative splicing factors. RNA 2010, 16:405-416.
32. Terenzi F., Ladd A.N. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity. RNA Biol 2010, 7:43-55.
33. Witten J.T., Ule J. Understanding splicing regulation through RNA splicing maps. Trends Genet 2011, 27:89-97.
34. Venables J.P., Klinck R., Koh C., Gervais-Bird J., Bramard A., Inkel L., Durand M., Couture S., Froehlich U., Lapointe E., et al. Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 2009, 16:670-676.
35. Yeo G.W., Coufal N.G., Liang T.Y., Peng G.E., Fu X.D., Gage F.H. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat Struct Mol Biol 2009, 16:130-137.
36. Zhang C., Zhang Z., Castle J., Sun S., Johnson J., Krainer A.R., Zhang M.Q. Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev 2008, 22:2550-2563.
37. Du H., Cline M.S., Osborne R.J., Tuttle D.L., Clark T.A., Donohue J.P., Hall M.P., Shiue L., Swanson M.S., Thornton C.A., et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 2010, 17:187-193.
38. Goers E.S., Purcell J., Voelker R.B., Gates D.P., Berglund J.A. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res 2010, 38:2467-2484.
39. Llorian M., Schwartz S., Clark T.A., Hollander D., Tan L.Y., Spellman R., Gordon A., Schweitzer A.C., de la Grange P., Ast G., et al. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat Struct Mol Biol 2010, 17:1114-1123.
40. Kalsotra A., Wang K., Li P.F., Cooper T.A. MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development. Genes Dev 2010, 24:653-658.
41. Kalsotra A., Xiao X., Ward A.J., Castle J.C., Johnson J.M., Burge C.B., Cooper T.A. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci U S A 2008, 105:20333-20338.
42. Bland C.S., Wang E.T., Vu A., David M.P., Castle J.C., Johnson J.M., Burge C.B., Cooper T.A. Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Res 2010, 38:7651-7664.
43. Terenzi F., Brimacombe K.R., Penn M.S., Ladd A.N. CELF-mediated alternative splicing is required for cardiac function during early, but not later, postnatal life. J Mol Cell Cardiol 2009, 46:395-404.
44. Boutz P.L., Chawla G., Stoilov P., Black D.L. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev 2007, 21:71-84.
45. Feng Y., Valley M.T., Lazar J., Yang A.L., Bronson R.T., Firestein S., Coetzee W.A., Manley J.L. SRp38 regulates alternative splicing and is required for Ca(2+) handling in the embryonic heart. Dev Cell 2009, 16:528-538.
46. Xu X., Yang D., Ding J.H., Wang W., Chu P.H., Dalton N.D., Wang H.Y., Bermingham J.R., Ye Z., Liu F., et al. ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 2005, 120:59-72.
47. Pistoni M., Ghigna C., Gabellini D. Alternative splicing and muscular dystrophy. RNA Biol 2010, 7:441-452.
48. O'Rourke J.R., Swanson M.S. Mechanisms of RNA-mediated disease. J Biol Chem 2009, 284:7419-7423.
49. Cooper T.A., Wan L., Dreyfuss G. RNA and disease. Cell 2009, 136:777-793.
50. Kong S.W., Hu Y.W., Ho J.W., Ikeda S., Polster S., John R., Hall J.L., Bisping E., Pieske B., dos Remedios C.G., et al. Heart failure-associated changes in RNA splicing of sarcomere genes. Circ Cardiovasc Genet 2010, 3:138-146.
51. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., Thornton C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289:1769-1773.
52. Orengo J.P., Chambon P., Metzger D., Mosier D.R., Snipes G.J., Cooper T.A. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A 2008, 105:2646-2651.
53. Lin X., Miller J.W., Mankodi A., Kanadia R.N., Yuan Y., Moxley R.T., Swanson M.S., Thornton C.A. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 2006, 15:2087-2097.
54. Timchenko L.T., Miller J.W., Timchenko N.A., DeVore D.R., Datar K.V., Lin L., Roberts R., Caskey C.T., Swanson M.S. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 1996, 24:4407-4414.
55. Miller J.W., Urbinati C.R., Teng-Umnuay P., Stenberg M.G., Byrne B.J., Thornton C.A., Swanson M.S. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000, 19:4439-4448.
56. Kuyumcu-Martinez N.M., Wang G.S., Cooper T.A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 2007, 28:68-78.
57. Yuan Y., Compton S.A., Sobczak K., Stenberg M.G., Thornton C.A., Griffith J.D., Swanson M.S. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res 2007, 35:5474-5486.
58. Warf M.B., Berglund J.A. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA 2007, 13:2238-2251.
59. Teplova M., Patel D.J. Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1. Nat Struct Mol Biol 2008, 15:1343-1351.
60. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001, 29:40-47.
61. Charlet B.N., Savkur R.S., Singh G., Philips A.V., Grice E.A., Cooper T.A. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002, 10:45-53.
62. Mankodi A., Takahashi M.P., Jiang H., Beck C.L., Bowers W.J., Moxley R.T., Cannon S.C., Thornton C.A. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002, 10:35-44.
63. Osborne R.J., Lin X., Welle S., Sobczak K., O'Rourke J.R., Swanson M.S., Thornton C.A. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 2009, 18:1471-1481.
64. Koshelev M., Sarma S., Price R.E., Wehrens X.H., Cooper T.A. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum Mol Genet 2010, 19:1066-1075.
65. Ward A.J., Rimer M., Killian J.M., Dowling J.J., Cooper T.A. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum Mol Genet 2010, 19:3614-3622.
66. Wheeler T.M., Lueck J.D., Swanson M.S., Dirksen R.T., Thornton C.A. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest 2007, 117:3952-3957.
67. Arambula J.F., Ramisetty S.R., Baranger A.M., Zimmerman S.C. A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding. Proc Natl Acad Sci U S A 2009, 106:16068-16073.
68. Warf M.B., Nakamori M., Matthys C.M., Thornton C.A., Berglund J.A. Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc Natl Acad Sci U S A 2009, 106:18551-18556.
69. Wheeler T.M., Sobczak K., Lueck J.D., Osborne R.J., Lin X., Dirksen R.T., Thornton C.A. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009, 325:336-339.
70. Shukla S., Fisher S.A. Tra2beta as a novel mediator of vascular smooth muscle diversification. Circ Res 2008, 103:485-492.
71. Zhang C., Frias M.A., Mele A., Ruggiu M., Eom T., Marney C.B., Wang H., Licatalosi D.D., Fak J.J., Darnell R.B. Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Science 2010, 329:439-443.